US2008145419A1PendingUtilityA1

High viscosity liquid controlled delivery system and medical or surgical device

Assignee: DURECT CORPPriority: Dec 10, 2002Filed: Jul 31, 2007Published: Jun 19, 2008
Est. expiryDec 10, 2022(expired)· nominal 20-yr term from priority
A61K 8/60A61L 2300/43A61Q 5/006A61K 47/26A61L 2300/252A61L 26/0066A61K 9/4858A61L 2300/402A61L 24/0026A61K 9/0024A61L 15/20A61K 9/7015A61K 47/14A61L 27/54A61K 9/0073A61L 2300/602A61L 31/16A61L 15/44A61K 47/34A61K 9/0014A61K 47/10A61L 24/0015A61K 9/0019A61K 9/1647
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to novel nonpolymeric compounds and compositions that form liquid, high viscosity materials suitable for the delivery of biologically active substances in a controlled fashion, and for use as medical or surgical devices. The materials can optionally be diluted with a solvent to form a material of lower viscosity, rendering the material easy to administer. This solvent may be water insoluble or water soluble, where the water soluble solvent rapidly diffuses or migrates away from the material in vivo, leaving a higher viscosity liquid material.

Claims

exact text as granted — not AI-modified
1 - 45 . (canceled) 
     
     
         46 . A composition for the controlled release delivery of a substance, said composition comprising sucrose acetate isobutyrate (SAIB) and a substance to be delivered. 
     
     
         47 . The composition of  claim 46 , wherein the substance to be delivered is a biologically active substance. 
     
     
         48 . The composition of  claim 47 , wherein the biologically active substance is a drug, peptide, protein, carbohydrate, nucleoprotein, mucoprotein, lipoprotein, synthetic polypeptide or protein, or a small molecule linked to a protein, glycoprotein, steroid, nucleic acid or a fragment thereof, nucleotide, nucleoside, oligonucleotide, gene, lipid, hormone or vitamin. 
     
     
         49 . The composition of  claim 48 , wherein the drug is an immunosuppressant, antioxidant, anesthetic, chemotherapeutic agent, steroid, hormone, antibiotic, antiviral, antifungal, antiproliferative, antihistamine, anticoagulant, antiphotoaging agent, melanotropic peptide, nonsteroidal or steroidal anti-inflammatory compound, antipsychotic or a radiation absorber. 
     
     
         50 . The composition of  claim 49 , wherein the anesthetic is selected from the group consisting of benzocaine, bupivacaine, levobupivacaine, lidocaine, mepivacaine, prilocalne, procaine, ropivacaine, and tetracaine. 
     
     
         51 . The composition of  claim 46 , wherein said composition is suitable for administration by injection. 
     
     
         52 . The composition of  claim 46 , wherein said composition is suitable for forming a medical or surgical implant.

Join the waitlist — get patent alerts

Track US2008145419A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.